Origen de la red de primer grado Charles Askew.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Nabgen, Inc.
1
| Private Company | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Charles Askew a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
GeneVentiv Therapeutics, Inc.
 GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Biotechnology | Founder |
Estadísticas
Internacional
| Estados Unidos | 2 |
Sectorial
| Health Technology | 2 |
Operativa
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Chengwen Li | 2 |
- Bolsa de valores
- Insiders
- Charles Askew
- Conexiones Empresas
